Duvortuxizumab
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E[1].
Product Specifications
CAS Number
1831098-91-9
Product Name Alternative
MGD 011
UNSPSC
12352203
Target
CD19; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/duvortuxizumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Duvortuxizumab]
Molecular Weight
(145.012 kDa)
References & Citations
[1]Duvortuxizumab. IMGT.|[2]Liu L, et al., MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clin Cancer Res. 2017 Mar 15;23 (6) :1506-1518.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog